Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)

OBJECTIVE—In patients with type 2 diabetes, left ventricular hypertrophy (LVH) predicts cardiovascular events, and the prevention of LVH is cardioprotective. We sought to compare the effect of ACE versus non-ACE inhibitor therapy on incident electrocardiographic (ECG) evidence of LVH (ECG-LVH). RESE...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Ruggenenti, Piero, Iliev, Ilian, Costa, Grazia Maria, Parvanova, Aneliya, Perna, Annalisa, Giuliano, Giovanni Antonio, Motterlini, Nicola, Ene-Iordache, Bogdan, Remuzzi, Giuseppe
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Diabetes Association 2008
Ämnen:
Cardiovascular and Metabolic Risk
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2494629/
https://ncbi.nlm.nih.gov/pubmed/18443191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-0371
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk